See other companies on Welcome to the Jungle
Stitch
Understand and improve patient experiences on clinical trials
- 1-20 employees
- Healthcare
- B2B
- SaaS
- London, UK
Jump to section
Company mission
To make clinical trials better by measuring each patient’s experience.
33% female employees
Our take
Clinical trials, crucial for developing life-saving treatments, are often plagued by high drop-out rates, hindering progress and costing millions. Stitch tackles this problem by focusing on the biggest untapped opportunity: understanding and improving the patient experience.
Stitch provides patients with tools to manage their journey, provide real-time feedback, and feel heard. This includes user-friendly mobile apps, clear communication, and access to support resources. Through this shift, Stitch aims to transform trials from burdensome experiences to valuable partnerships between patients and researchers.
This innovative approach has attracted partnerships with Cancer Research UK and Langland. Collaborations like this show Stitch's commitment to benefiting both patients and research through better trial design. As Stitch refines its platform and expands its reach, it has the potential to revolutionise clinical trials, making them faster, more efficient, and ultimately, more successful for everyone.
Kirsty
Company Specialist at Welcome to the Jungle
Benefits
- Share options scheme
- Pension
- Fantastic office in convenient location
- 25 days holiday allowance
- Ongoing training and development opportunities, with dedicated budget
- Monthly socials and team activities
- Company MacBook
Company values
- Patients first: We ask "what's best for patients" to guide each decision
- Act with integrity: We do the right thing for our users, our customers, and our team
- Pursue impact: We do what brings the most value, the fastest
- Be direct: We communicate directly, and with empathy
- Think and build for long term: We consider the long-term implications of any decision we make
Funding (2 rounds)
Sep 2022
$3.2m
SEED
Oct 2021
$0.6m
ANGEL
Total funding: $3.8m
Leadership
Jonathan Moshinsky
(CEO)15 years experience building life sciences technology. Previously the CSO at uMotif, and prior to that held senior roles at industry leaders Veeva and IBM.
James Allen
(CTO)With a PhD from Cambridge, James has previously built products in the life sciences and technology space as Head of Data at uMotif. Before that, he worked at Sandtable in various Data Science roles.
Mike Sterling
(COO)10 years experience in building startups, most recently as Director of Marketing, Finance, and Strategy at Deliveroo. Prior to that, Mike worked at IBM, onefinestay, Jinn, and Bloom & Wild.
Articles
